Aurora Cannabis (ACB) Other Non-Current Assets (2017 - 2025)
Aurora Cannabis (ACB) reported Other Non-Current Assets of $3.4 million for Q4 2025, down 47.39% year-over-year from $6.6 million in Q4 2024, and down 15.94% quarter-over-quarter from $4.1 million in Q3 2025.
Aurora Cannabis (ACB) Other Non-Current Assets (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Other Non-Current Assets data on file, last reported at $3.4 million in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $3.4 million, down 47.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (down 47.39% YoY), and the FY2025 annual result was $5.4 million, down 39.71% from the prior year.
- Other Non-Current Assets eased to $3.4 million in Q4 2025 per ACB's latest filing, from $4.1 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $13.1 million in Q4 2022 and troughed at -$7.0 million in Q1 2021.
- A 5-year average of $5.5 million and a median of $5.0 million in 2025 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets tumbled 83.93% in 2021, then jumped 1678.92% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $733835.9 in 2021, then jumped by 1678.92% to $13.1 million in 2022, then fell by 26.89% to $9.5 million in 2023, then slumped by 31.32% to $6.6 million in 2024, then sank by 47.39% to $3.4 million in 2025.
- Business Quant data shows ACB's Other Non-Current Assets at $3.4 million in Q4 2025, $4.1 million in Q3 2025, and $4.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 3.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 4.10 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 5.38 Mn |
| Dec 31, 2024 | 6.56 Mn |
| Sep 30, 2024 | 7.43 Mn |
| Jun 30, 2024 | 8.10 Mn |
| Mar 31, 2024 | 8.93 Mn |
| Dec 31, 2023 | 9.54 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 11.87 Mn |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 13.05 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 733,835.88 |
| Sep 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | 2.88 Mn |
| Mar 31, 2021 | -7.02 Mn |